Prostaglandin E2 EP2 and EP4 receptor activation mediates cAMP-dependent hyperpolarization and exocytosis of renin in juxtaglomerular cells

American Journal of Physiology - Renal Physiology

Volumn 289, Issue 5 58-5, 2005, Pages

  Friis, Ulla G ^a   Stubbe, Jane ^a   Uhrenholt, Torben R ^a   Svenningsen, Per ^a   Nüsing, Rolf M ^b   Skøtt, Ole ^a   Jensen, Boye L ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Capacitance; Current; Cyclooxygenase; Kidney; Potential

Indexed keywords

BUTAPROST; COMPLEMENTARY DNA; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; IBERIOTOXIN; ILOPROST; ISOBUTYLMETHYLXANTHINE; LIGAND; MESSENGER RNA; PHOSPHODIESTERASE INHIBITOR; POTASSIUM CHANNEL BLOCKING AGENT; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; RENIN; PROSTAGLANDIN E2 RECEPTOR, EP4 SUBTYPE; PROSTAGLANDIN EP2 RECEPTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EXOCYTOSIS; GRANULE CELL; HYPERPOLARIZATION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; JUXTAGLOMERULAR APPARATUS; KIDNEY; KIDNEY CORTEX; MEMBRANE POTENTIAL; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; RENIN RELEASE; ANIMAL; CELL MEMBRANE POTENTIAL; CYTOLOGY; MALE; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; EXOCYTOSIS; JUXTAGLOMERULAR APPARATUS; MALE; MEMBRANE POTENTIALS; PATCH-CLAMP TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PROSTAGLANDIN E; RENIN;

EID: 26844466899     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00201.2005     Document Type: Article

References (45)

1. Audoly LP, Tille SL, Goulet J, Key M, Nguyen MT, Stock J, McNeish J, Koller BH, and Coffman TM. Identification of specific EP receptors responsible for the hemodynamic effects of PGE2. Am J Physiol Heart Circ Physiol 277: H924-H930, 1999.
2. 2 receptor EP4 subtype is essential for agonist-induced desensitization. Mol Pharmacol 51: 343-349, 1997.
3. 2 receptor subtypes. Eur J Pharmacol 340: 227-241, 1997.
4. Breyer MD, Davis L, Jacobsson HR, and Breyer R. Differential localization of prostaglandin E receptor subtypes in human kidney. Am J Physiol Renal Fluid Electrolyte Physiol 270: F912-F918, 1996.
5. Cheng HF, Wang JL, Zhang MZ, McKanna JA, and Harris RC. Role of p38 in the regulation of renal cortical cyclooxygenase-2 expression by extracellular chloride. J Clin Invest 106: 681-688, 2000.
6. Cheng HF, Wang SW, Zhang MZ, McKanna JA, Breyer R, and Harris RC. Prostaglandins that increase renin production in response to ACE inhibition are not derived from cyclooxygenase-1. Am J Physiol Regul Integr Comp Physiol 283: R638-R646, 2002.
7. Coleman RA, Smith WL, and Narumiya SVIII. International union of pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 46: 205-229, 1994.
8. Desai S, April H, Nwaneshiudu, and Ashby B. Comparison of agonist-induced internalization of the human EP2 and EP4 prostaglandin receptors: role of the carboxyl terminus in EP4 receptor sequestration. Mol Pharmacol 58: 1279-1286, 2000.
9. 2 synthesis along the rabbit nephron. Am J Physiol Renal Fluid Electrolyte Physiol 252: F53-F59, 1987.
10. Francisco LL, Osborn JL, and DiBona GF. Prostaglandin in renin release during sodium deprivation. Am J Physiol Renal Fluid Electrolyte Physiol 243: F537-F542, 1982.
11. Friis UG, Jensen BL, Sethi S, Andreasen D, Hansen PB, and Skøtt O. Control of renin secretion from rat juxtaglomerular cells by cAMP-specific phosphodiesterases. Circ Res 90: 996-1003, 2001.
12. Ca potassium channels (ZERO variant) and L-type voltage-dependent calcium channels in single rat juxtaglomerular cells. Circ Res 93: 213-220, 2003.
13. 2. J Biol Chem 277: 2614-2619, 2002.
14. 2 induced functional expression of early growth response factor-1 by EP4, but not EP2, prostanoid receptors via the phosphatidylinositol 3-kinase and extracellular signal-regulated kinases. J Biol Chem 278: 12151-12156, 2003.
15. 2 receptor IP. J Clin Invest 114: 805-812, 2004.
16. 2 receptor EP2 in rat and human mesangioproliterative glomerulonephritis. Inflamm Res 49: 345-354, 2000.
17. 2 receptors to renal microvascular reactivity in mice. Am J Physiol Renal Physiol 283: F415-F422, 2002.
18. Jensen BL, Schmid C, and Kurtz A. Prostaglandins stimulate renin secretion and renin mRNA in mouse renal juxtaglomerular cells. Am J Physiol Renal Fluid Electrolyte Physiol 271: F659-F669, 1996.
19. Jensen BL, Mann B, Skøtt O, and Kurtz A. Differential regulation of renal prostaglandin receptor mRNAs by dietary salt intake in the rat. Kidney Int 56: 528-537, 1999.
20. 2 EP2 and EP4 receptors in the rat kidney. Am J Physiol Renal Physiol 280: F1001-F1009, 2001.
21. Kabashima K, Saji T, Murata T, Nagamachi M, Matsuoka T, Segi E, Tsuboi K, Sugimoto Y, Kobayashi T, Miyachi Y, Ichikawa A, and Narumiya S. The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. J Clin Invest 109: 883-893, 2002.
22. Kammerl MC, Nusing RM, Schwede F, Endemann D, Stubanus M, Kees F, Lackner KJ, Fischereder M, and Kramer BK. Low sodium and furosemide-induced stimulation of the renin system in man is mediated by cyclooxygenase 2. Clin Pharmacol Ther 70: 468-474, 2001.
23. Kennedy CRJ, Zhang Y, Brandon S, Guan Y, Coffee K, Funk CD, Magnuson MA, Oates JA, Breyer MD, and Breyer RM. Salt-sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor. Nature Med 5: 217-220, 1999.
24. Lydford SJ, McKechnie KCW, and Dougall IG. Pharmacological studies on prostanoid receptors in the rabbit isolated saphenous vein: a comparison with the rabbit isolated ear artery. Br J Pharmacol 117: 13-20, 1996.
25. Lykkegaard S and Poulsen K. Ultramicroassay for plasma renin concentration in the rat using the antibody trapping technique. Analyt Biochem 75: 250-259, 1976.
26. 2 receptor proteins EP1, EP2, EP3 and EP4 in human kidney. J Am Soc Nephrol 1851-1860, 1999.
27. 2 receptor of the EP2 subtype. Prostaglandins 54: 713-725, 1997.
28. Nishigaki N, Negishi M, and Ichikawa A. Two Gs-coupled prostaglandin E receptor subtypes, EP2 and EP4, differ in desensitization and sensitivity to the metabolic inactivation of the agonist. Mol Pharmacol 50: 1031-1037, 1996.
29. 2 release from macula densa cells. J Clin Invest 112: 76-82, 2003.
30. 2 actions in the microcirculation of rat kidney. Am J Physiol Renal Physiol 279: F755-F764, 2000.
31. Reinalter SC, Jeck N, Brochhausen C, Watzer B, Nusing RM, Seyberth HW, and Komhoff M. Role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Banter syndrome. Kidney Int 62: 253-260, 2002.
32. Romero JC, Dunlap CL, and Strong CG. The effect of indomethacin and other anti-inflammatory drugs on the renin-angiotensin system. J Clin Invest 58: 282-288, 1976.
33. Sando T, Usui T, Tanaka L, Mori K, Sasaki Y, Fukuda Y, Namba T, Sugimoto Y, Ichikawa A, Narumiya S, and Nakao K. Molecular cloning and expression of rat prostaglandin E receptor EP2 subtype. Biochem Biophys Res Commun 200: 1329-1333, 1999.
34. 2 is mediated by EP2 and EP4 receptors in mouse kidneys. Am J Physiol Renal Physiol 287: F427-F433, 2004.
35. Sugimoto Y, Namba T, Shigemoto R, Negishi M, Ichikawa A, and Narumiya S. Distinct cellular localization of mRNAs for three subtypes of prostaglandin E receptor in kidney. Am J Physiol Renal Fluid Electrolyte Physiol 266: F823-F828, 1994.
36. Suzawa T, Miyaura C, Inada M, Maruyama T, Sugimoto Y, Ushikubi F, Ichikawa A, Narumiya S, and Suda T. The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs. Endocrinology 141: 1554-1559, 2000.
37. 2 on the renal afferent arteriole. Circ Res 86: 663-670, 2000.
38. 2 EP4 receptors. J Am Soc Nephrol 15: 1189-1198, 2004.
39. 2 receptor. J Clin Invest 103: 1539-1545, 1999.
40. Traynor Smart A TR, Briggs JP, and Schnermann J. Inhibition of macula densa-stimulated renin secretion by pharmacological blockade of cyclooxygenase-2. Am J Physiol Renal Physiol 277: F706-F710, 1999.
41. Wang JL, Cheng HF, and Harris RC. Cyclooxygenase-2 inhibition decreases renin content and lowers blood pressure in a model of renovascular hypertension. Hypertension 34: 96-101, 1999.
42. 2 release and cyclooxygenase-2 expression in a mouse macula densa cell line. J Biol Chem 275: 37922-37929, 2000.
43. 2 stimulates vascular smooth muscle cell proliferation via the EP2 receptor. Mol Cell Endocrinol 203: 77-90, 2003.
44. 2 receptors. Hypertension 35: 1129-1134, 2000.
45. 2 action in human coronary artery smooth; Role of potassium channels and signaling cross-talk. J Vasc Res 39: 477-488, 2001.